Fig. 1From: Synaptic vesicle glycoprotein 2 A in serum is an ideal biomarker for early diagnosis of Alzheimer’s diseaseFlowchart for subject enrolment and exclusionAbbreviations: AD, Alzheimer’s disease; aMCI, amnestic mild cognitive impairment; CSF, cerebrospinal fluid; GFAP, glial fibrillary acidic protein; NfL, neurofilament light; PDD, Parkinson’s disease dementia; Simoa, single molecule array; SV2A, synaptic vesicle glycoprotein 2 A; VaD, vascular dementia.Back to article page